×
About 16,623 results

ALLMedicine™ Contraception Center

Research & Reviews  4,972 results

Impact of contraceptive coverage policies on contraceptive use and risky sexual behavio...
https://doi.org/10.1093/pubmed/fdab387
Journal of Public Health (Oxford, England); Paul PL, Pace LE et. al.

Dec 2nd, 2021 - This study used representative data to examine the impact of changes in contraceptive coverage policies (contraceptive insurance mandates and pharmacy access to emergency contraception) on contraceptive use and risky sexual behavior among adolesce...

INTRAUTERINE DEVICE, SUBDERMAL CONTRACEPTIVE, AND DEPOT MEDROXYPROGESTERONE USE AMONG T...
https://doi.org/10.1016/j.contraception.2021.11.001
Contraception Berglin M, Stram D et. al.

Dec 2nd, 2021 - To describe use of three types of longer acting contraception-intrauterine devices, subdermal contraceptives, and depot medroxyprogesterone-among transmasculine and cisgender women patients. A repeated cross-sectional study using electronic medica...

Contraceptive method preference and reasons for contraceptive discontinuation among wom...
https://doi.org/10.1016/j.contraception.2021.11.002
Contraception Beesham I, Bosman S et. al.

Dec 2nd, 2021 - The use of intrauterine devices (IUDs) and contraceptive implants in South Africa (SA) is low with limited data on patterns of use and reasons for discontinuation. We describe contraceptive preferences and reasons for discontinuation among women e...

Gendered power dynamics and threats to sexual and reproductive autonomy among adolescen...
https://doi.org/10.1371/journal.pone.0257009
PloS One; Decker MR, Wood SN et. al.

Nov 30th, 2021 - Gendered economic and social systems can enable relational power disparities for adolescent girls and young women (AGYW), and undercut autonomy to negotiate sex and contraceptive use. Less is known about their accumulation and interplay. This stud...

Contraceptive counselling experiences in Spain in the process of creating a web-based c...
https://doi.org/10.1186/s12978-021-01254-0 10.3109/13625187.2015.1028617 10.1016/j.jpag.2009.09.012 10.1016/j.contraception.2012.07.015 10.1016/j.contraception.2017.06.005 10.1016/j.ajog.2015.01.051 10.1016/j.contraception.2015.12.010 10.1363/4419412 10.1016/j.amjcard.2016.11.047 10.1097/GRF.0000000000000059 10.1111/sifp.12092 10.1186/s13012-019-0941-z 10.1186/s12978-018-0569-5 10.4324/9781315429250 10.1191/1478088706qp063oa 10.1363/46e2114 10.1080/13625187.2018.1563065 10.1016/s0002-9378(97)70552-0 10.1016/j.contraception.2017.07.007 10.1016/j.ajog.2016.01.173 10.1001/jama.1992.03480160079038 10.1016/j.gaceta.2011.10.005 10.1186/s40834-018-0057-x 10.1016/j.contraception.2016.12.010 10.1016/j.whi.2018.09.004 10.1016/j.contraception.2012.10.012 10.1016/j.contraception.2012.10.011 10.1136/jfprhc-2014-100956 10.1016/j.whi.2014.02.003 10.1016/j.contraception.2017.10.004 10.1363/46e1814 10.1016/j.jadohealth.2010.03.014 10.1016/j.jpag.2008.05.008 10.1016/j.contraception.2004.04.013 10.1016/s0029-7844(01)01764-1 10.1016/s0010-7824(01)00181-0 10.1016/j.contraception.2018.12.006 10.1186/s12978-020-01037-z 10.1016/j.pec.2016.08.022 10.1016/j.contraception.2019.08.001 10.1016/j.amepre.2018.07.006 10.2105/AJPH.2006.092585 10.1363/4020208 10.1016/S0213-9111:76090-4 10.1186/s12889-019-7572-9 10.1136/bmj.e256 10.1634/theoncologist.5-4-302
Reproductive Health; Reyes-Martí L, Rubio-Rico L et. al.

Nov 29th, 2021 - The choice of contraceptive method is a complex decision, and professionals should offer counselling based on the preferences, values and personal situation of the user(s). Some users are unsatisfied with the counselling received, which may, among...

see more →

Guidelines  41 results

Committee Opinion No. 419: Coercion Free Contraceptive Care.
https://doi.org/10.1016/j.jogc.2021.07.001
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Black A, Bow M et. al.

Jul 10th, 2021 - To provide guidance on culturally competent contraception counselling that is free of coercion and promotes shared decision-making and patient autonomy. Individuals of reproductive age who seek contraception or counselling for family planning. Con...

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200366
Maturitas Ramírez I, De la Viuda E et. al.

Jun 6th, 2020 - COVID-19 is associated with a systemic inflammatory response with activation of coagulation in symptomatic patients. The possibility of coagulopathies in peri- and postmenopausal women taking estrogen therapies makes it necessary to consider antit...

Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recomm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147901
MMWR. Morbidity and Mortality Weekly Report; Tepper NK, Curtis KM et. al.

Apr 10th, 2020 - "U.S. Medical Eligibility Criteria for Contraceptive Use" (U.S. MEC) 2016 provides evidence-based guidance for the safe use of contraceptive methods among U.S. women with certain characteristics or medical conditions (1). The U.S. MEC is adapted f...

2020 American College of Rheumatology Guideline for the Management of Reproductive Heal...
https://doi.org/10.1002/art.41191
Arthritis & Rheumatology (Hoboken, N.J.) References; Sammaritano LR, Bermas BL et. al.

Feb 25th, 2020 - To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, and medic...

Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy.
https://doi.org/10.1016/j.ajog.2020.01.030
American Journal of Obstetrics and Gynecology; , Miller R et. al.

Jan 24th, 2020 - Cesarean scar pregnancy is a complication in which an early pregnancy implants in the scar from a prior cesarean delivery. This condition presents a substantial risk for severe maternal morbidity because of challenges in securing a prompt diagnosi...

see more →

Drugs  320 results see all →

Clinicaltrials.gov  278 results

The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study
https://clinicaltrials.gov/ct2/show/NCT05135013

Nov 25th, 2021 - Methodology Design. A case-controlled study. Setting. Breast cancer clinic and breast cancer screening unit at clinical oncology department, Ain Shams University hospital Participants. All cases who will be screened from the BC clinic and the BC s...

Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants
https://clinicaltrials.gov/ct2/show/NCT03048422

Nov 24th, 2021 - This study compared the virologic efficacy and safety of three ARV regimens in pregnant women living with HIV: dolutegravir (DTG) plus emtricitabine/tenofovir alafenamide (FTC/TAF), DTG plus emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), a...

Factors Associated With the Absence of Contraception at Women Seeking a Voluntary Termination of Pregnancy
https://clinicaltrials.gov/ct2/show/NCT04830007

Nov 23rd, 2021 - In 1967, the Neuwirth law allowed women to control their fertility by establishing the right to contraception as a principle. Since then, they have continued to take ownership of the various contraceptive methods, which are regularly renewed. Cont...

MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS Study
https://clinicaltrials.gov/ct2/show/NCT01961375

Nov 19th, 2021 - The study is designed as non interventional to observe the continuation rate and the patient satisfaction in women who have a LNG-IUS (Levonorgestrel releasing Intrauterine system) inserted for contraception over the period of 12 months under real...

A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
https://clinicaltrials.gov/ct2/show/NCT04969939

Nov 19th, 2021 - The study is looking at a new medicine to help people lose weight. In this study participants will either get semaglutide and NNC0165-1875 or semaglutide and a "dummy" medicine (placebo). Which treatment participants get is decided by chance. Part...

see more →

News  1,037 results

SCOTUS Oral Arguments in Major Abortion Case Touch on Liberty, Viability Standard
https://www.medpagetoday.com/obgyn/pregnancy/95965

Dec 1st, 2021 - WASHINGTON -- Wednesday's oral arguments at the Supreme Court in a case that could have profound effects on abortion laws in the U.S. encompassed a wide range of issues, from the effectiveness of contraception to questions of fundamental liberty a...

A Third of Women Do Not Confirm They Are Pregnant Until 6 Weeks or Later
https://www.medscape.com/viewarticle/962831

Nov 15th, 2021 - NEW YORK (Reuters Health) - More than a third of women and girls do not confirm they are pregnant until they are six weeks or further along and one in five don't know until they are at seven weeks or later, a U.S. study finds. An analysis of data ...

Texas Practitioners See Increased Interest in Birth Control Since Near-Total Abortion Ban
https://www.medscape.com/viewarticle/962489

Nov 8th, 2021 - In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnan...

Hormonal Contraceptives and the Risk of Inflammatory Bowel Disease
https://www.medscape.com/viewarticle/961844

Oct 29th, 2021 - Takeaway Longer exposure to combined oral contraceptive pills (COCPs), but not to progestogen-only pills (POPs), was associated with an increased risk of Crohn's disease (CD). Exposure to COCPs and POPs was associated with a moderate increase in t...

The male biological clock – How to tell the time
https://www.mdedge.com/obgyn/article/247840/reproductive-endocrinology/male-biological-clock-how-tell-time
Mark P. Trolice, MD

Oct 25th, 2021 - For decades, we have recognized the age-related natural decline in female fecundity (the ability to reproduce) after the age of 30 (Maturitas 1988;[Suppl]1:15-22). Advanced maternal age (AMA) has also been demonstrated to increase miscarriage and.

see more →

Patient Education  1 results see all →